Polynerve ⚠ Under review

Under review — some data on this profile may be inaccurate and is being re-verified.

Developer of medical devices intended for the peripheral nerve injury repair procedure and regeneration.

Other Devices and Supplies
Active
Manchester, United Kingdom Founded 2022
Last updated 2026-08-21
Total raised
$4.3M
Stage
—
Founded
2022
Headcount
—
HQ
Manchester, United Kingdom
Sector
Other Devices and Supplies

About

Polynerve is a medical device company focused on developing solutions for peripheral nerve injury repair and regeneration. The company offers a bioresorbable polymer nerve conduit designed to support directional nerve regeneration, aiming to eliminate the need for autologous nerve grafts and reduce associated risks and complications. Their technology features a micro-grooved internal lumen to enhance Schwann cell infiltration and guide nerve growth. Polynerve has completed Phase I clinical trials.

Funding history · 2 rounds · $4.3M total

2 events/rounds · $4.3M Total Funding: $4.3M in Private Equity
Oct 2022
A Round Undisclosed ivc-online.com ↗
Jul 2022
Seed $4.3M pitchbook.com

Offices

Manchester, United Kingdom · HQ / main office

Q&A

What is Polynerve's primary business focus?
Polynerve is a medical device company that develops solutions for peripheral nerve injury repair and regeneration, specifically a bioresorbable polymer nerve conduit.
When was Polynerve founded?
Polynerve was founded in 2022.
What is the total funding Polynerve has raised to date?
Polynerve has raised a total of $4,290,000 across its funding rounds.
What is the latest known funding round for Polynerve?
Polynerve completed an A Round in October 2022.
What is the core technology offered by Polynerve?
Polynerve's core technology is a bioresorbable polymer nerve conduit designed to support directional nerve regeneration.
What is the purpose of Polynerve's nerve conduit technology?
The nerve conduit aims to eliminate the need for autologous nerve grafts and reduce associated risks and complications in peripheral nerve injury repair.
Has Polynerve conducted clinical trials for its technology?
Yes, Polynerve has completed Phase I clinical trials for its medical device.
Who is the CEO of Polynerve?
Tomer Alon is the CEO of Polynerve.

Sectors & technology

Primary sector
Other Devices and Supplies
Technologies
Target customers
Business model
B2B
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websitenanochronia.com

Identifiers & details

Founded2022

Radar intelligence

Web history (Wayback)

Domainnanochronia.com